Skip to main content
NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.15%AUDUSD-1.09%GBPCHF+1.01%USDCHF+0.93%GBPCAD+0.78%USDCAD+0.73%GBPNZD+0.73%NZDUSD-0.69%EURGBP-0.64%GBPJPY+0.61%USDTHB+0.60%EURUSD-0.58%AUDJPY-0.57%USDJPY+0.55%EURAUD+0.53%PLNJPY+0.44%GBPTRY+0.41%AUDNZD-0.41%AUDCAD-0.39%SGDJPY+0.36%NOKJPY+0.35%CHFJPY-0.35%EURCHF+0.34%GBPHKD+0.32%USDTRY+0.29%GBPMXN-0.28%NZDCHF+0.25%CADCHF+0.21%AUDCHF-0.19%CADJPY-0.17%USDILS+0.16%AUDNOK+0.15%EURCAD+0.15%AUDSGD+0.14%USDCNH-0.12%NZDJPY-0.12%EURNZD+0.12%USDZAR+0.11%USDNOK+0.10%NZDMXN-0.10%USDSGD+0.10%AUDDKK+0.08%USDMXN+0.07%EURNOK+0.07%USDSEK+0.06%EURZAR+0.06%EURHKD-0.06%GBPUSD+0.06%EURSGD+0.06%CHFNOK+0.05%NZDSGD-0.05%NZDCAD+0.04%CHFSGD+0.04%USDDKK+0.04%USDCOP-0.04%EURJPY-0.04%USDHKD+0.03%EURCNH+0.03%EURSEK+0.03%GBPZAR+0.03%EURPLN-0.02%USDPLN+0.02%GBPSGD+0.02%EURCZK+0.01%CHFSEK+0.01%EURDKK0.00%GAGUSD+1.25%XAGUSD+1.24%USOIL-0.86%HG1-0.70%UKOIL-0.68%S1-0.39%XNGUSD-0.30%XAUUSD+0.22%GAUUSD+0.22%C1-0.17%W1-0.11%XPTUSD+0.10%BTCUSD-0.23%ETHUSD+7.44%USDTUSD-0.03%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+0.89%ZECUSDT-0.11%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.88%XLMUSD+2.32%BCHUSDT-0.35%UNIUSD-0.34%LTCUSD+0.07%HBARUSDT+2.33%SUIUSD+2.30%TONUSD+15.77%TAOUSDT+1.09%AAVEUSD-0.94%DOTUSDT+3.87%ICPUSDT-1.20%ONDOUSDT+0.95%WLDUSDT+9.89%ARBUSDT+0.27%JUPUSDT-0.50%ATOMUSDT+2.67%INJUSDT-2.58%STXUSDT+19.27%FETUSDT+3.55%SEIUSDT+0.33%PYTHUSDT-1.87%TIAUSDT+1.52%IMXUSDT+2.18%GRTUSDT+0.25%OPUSDT+0.54%WIFUSDT+4.29%IOTAUSDT+6.25%POLUSDT-3.96%AXSUSDT+1.02%FARTCOINUSDT+0.32%EOSUSDT+4.39%DYDXUSDT+3.37%GALAUSDT+3.85%ORDIUSDT+2.08%NOTUSDT+1.55%RONINUSDT+1.63%NVDA+0.57%AAPL+0.41%GOOGL+0.93%MSFT+0.39%AMZN+0.36%TSM-0.16%SPCX+1.09%META+0.17%AVGO-1.10%TSLA+0.05%SKHY-1.36%MU+0.23%LLY-2.33%BRK-B-0.88%AMD+0.69%JPM-1.24%WMT-2.70%ASMLa-0.27%XOM+0.87%V-1.79%JNJ-1.06%INTC+3.71%0700.HK-0.23%MA-2.15%1398.HK+0.78%ABBV-0.65%CSCO+0.65%LRCX+1.44%CVX-0.08%AMAT-0.12%COST-1.54%AP2d+1.46%ORCL-0.35%BAC-0.96%CAT-1.92%KO-0.88%DELL-0.30%0005.HK-0.63%PG-2.05%HSBA.L-0.64%UNH-2.10%3988.HK+1.16%GE-1.76%1816.HK+0.48%ARM-1.37%0857.HK-0.51%0939.HK+1.34%1288.HK+0.61%PM-1.59%MS-2.43%GBPAUD+1.15%AUDUSD-1.09%GBPCHF+1.01%USDCHF+0.93%GBPCAD+0.78%USDCAD+0.73%GBPNZD+0.73%NZDUSD-0.69%EURGBP-0.64%GBPJPY+0.61%USDTHB+0.60%EURUSD-0.58%AUDJPY-0.57%USDJPY+0.55%EURAUD+0.53%PLNJPY+0.44%GBPTRY+0.41%AUDNZD-0.41%AUDCAD-0.39%SGDJPY+0.36%NOKJPY+0.35%CHFJPY-0.35%EURCHF+0.34%GBPHKD+0.32%USDTRY+0.29%GBPMXN-0.28%NZDCHF+0.25%CADCHF+0.21%AUDCHF-0.19%CADJPY-0.17%USDILS+0.16%AUDNOK+0.15%EURCAD+0.15%AUDSGD+0.14%USDCNH-0.12%NZDJPY-0.12%EURNZD+0.12%USDZAR+0.11%USDNOK+0.10%NZDMXN-0.10%USDSGD+0.10%AUDDKK+0.08%USDMXN+0.07%EURNOK+0.07%USDSEK+0.06%EURZAR+0.06%EURHKD-0.06%GBPUSD+0.06%EURSGD+0.06%CHFNOK+0.05%NZDSGD-0.05%NZDCAD+0.04%CHFSGD+0.04%USDDKK+0.04%USDCOP-0.04%EURJPY-0.04%USDHKD+0.03%EURCNH+0.03%EURSEK+0.03%GBPZAR+0.03%EURPLN-0.02%USDPLN+0.02%GBPSGD+0.02%EURCZK+0.01%CHFSEK+0.01%EURDKK0.00%GAGUSD+1.25%XAGUSD+1.24%USOIL-0.86%HG1-0.70%UKOIL-0.68%S1-0.39%XNGUSD-0.30%XAUUSD+0.22%GAUUSD+0.22%C1-0.17%W1-0.11%XPTUSD+0.10%BTCUSD-0.23%ETHUSD+7.44%USDTUSD-0.03%XRPUSD+0.63%SOLUSD-0.64%TRXUSDT+0.89%ZECUSDT-0.11%DOGEUSD-0.17%LINKUSD-2.08%XMRUSDT+0.88%XLMUSD+2.32%BCHUSDT-0.35%UNIUSD-0.34%LTCUSD+0.07%HBARUSDT+2.33%SUIUSD+2.30%TONUSD+15.77%TAOUSDT+1.09%AAVEUSD-0.94%DOTUSDT+3.87%ICPUSDT-1.20%ONDOUSDT+0.95%WLDUSDT+9.89%ARBUSDT+0.27%JUPUSDT-0.50%ATOMUSDT+2.67%INJUSDT-2.58%STXUSDT+19.27%FETUSDT+3.55%SEIUSDT+0.33%PYTHUSDT-1.87%TIAUSDT+1.52%IMXUSDT+2.18%GRTUSDT+0.25%OPUSDT+0.54%WIFUSDT+4.29%IOTAUSDT+6.25%POLUSDT-3.96%AXSUSDT+1.02%FARTCOINUSDT+0.32%EOSUSDT+4.39%DYDXUSDT+3.37%GALAUSDT+3.85%ORDIUSDT+2.08%NOTUSDT+1.55%RONINUSDT+1.63%
PP

Praxis Precision Medicines, Inc. (PRAX)

NASDAQ • Healthcare

$291.23
+$10.23 (+3.6%)
Market closed

Last close at September 30, 2026 at 20:00 UTC

Open$284.65
Day Range$282 - $296.15
Avg. Volume (3M)441.1K
Market Cap$8.1B
52 Week Range
$50.31$392.7
Next EarningsIn 39 daysNov 9, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$339.1M
EPS (TTM)
-$12.95
ROA (TTM)
-24.4%
Current Ratio
15.73

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-12.0%Q1 2026-$3.5
+10.6%Q2 2026-$3.2
+21.8%Q3 2026-$2.87
Next

Nov 9

in 39 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +21.8%

Praxis Precision Medicines’ preliminary results for the second fiscal quarter of 2026, reported August 6, 2026, showed EPS of -$2.87 topping the -$3.67 estimate by $0.80, while the clinical-stage CNS pipeline across small molecules and antisense programs continued to translate into sizable losses as it advances candidates such as PRAX-114, PRAX-944, and PRAX-562. GAAP operating income was a loss of about $96.9 million, and net income was a loss of roughly $83.7 million, down 17.7% year over year from a loss of about $71.1 million a year ago. Cash burn remained significant, with negative operating cash flow of around $77.6 million for the quarter. For the next period, consensus calls for EPS of -$3.65 on revenue of $130,769.00.

View full earnings history

About Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc. develops therapies for central nervous system disorders tied to imbalances in neuronal activity as a clinical-stage biopharmaceutical firm and clinical-stage Biotechnology company listed on NASDAQ as PRAX. Its pipeline spans small molecules and antisense medicines aimed at epilepsy, movement disorders, pain-related conditions, and depressive disorders, placing it in the drug-development end of the healthcare sector.

Name
Praxis Precision Medicines, Inc.
CEO
Marcio Silva De'Souza
Website
www.praxismedicines.com
Industry
Healthcare
Year Founded
2015
Employees
168

Today's Snapshot

AI-generated

PRAX closed 3.6% above yesterday's close, outperforming a weaker sector.

Trading Volume

Above 10d avg 598.6K

696.5K

vs S&P 500 Today

Strong Outperformance

+3.45%

Updated: September 30, 2026 at 20:12 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
PRAX shows pronounced technical deterioration: ADX around 27 indicates a developing downtrend and multiple momentum indicators are firmly negative—MACD and short-term momentum are deeply bearish. The current price of 291.23 is below most medium-term averages and beneath the 200-day level, despite a near-term SMA10 near the market, while ATR is elevated at about 15.58 (5.35%), signaling higher volatility. OBV points to distribution and the classic pivot at 282.85 lies below the market but does not offset the broad weakness. Technical takeaway: Strong Sell — momentum, trend and volume favor sellers.
All signals
  • EMA (5 indicators)$294.06 - $323.41
    Sell
  • RSI (14)36.17
    Neutral
  • Stochastic %K (14, 3, 3)13.29
    Buy
  • MACD Level (12, 26)-17.24
    Sell

Peers & Related Assets

KYMRKymera Therapeutics, Inc.
$111.79+1.2%
CRNXCrinetics Pharmaceuticals, Inc.
$84.950.0%
IMVTImmunovant, Inc.
$33.78+1.0%
LGNDLigand Pharmaceuticals Incorporated
$312.37+0.7%
VKTXViking Therapeutics, Inc.
$32.6+2.5%
XENEXenon Pharmaceuticals Inc.
$37.19-0.2%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.